A 29-week, double-blind, placebo-controlled study of glycomet gp metformin hydrochloride hydrochloride tablets and glyburide, alone and in combination, was conducted in obese patients with type 2 diabetes who had failed to achieve adequate glycemic control while on maximum doses...